These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 24829597)
1. Clinical and Electrophysiologic Responses to Acetylcholinesterase Inhibitors in MuSK-Antibody-Positive Myasthenia Gravis: Evidence for Cholinergic Neuromuscular Hyperactivity. Shin HY; Park HJ; Lee HE; Choi YC; Kim SM J Clin Neurol; 2014 Apr; 10(2):119-24. PubMed ID: 24829597 [TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Repetitive Compound Muscle Action Potentials in Patients with Myasthenia Gravis: A Predictor for Cholinergic Side Effects of Acetylcholinesterase Inhibitors. Lee HE; Kim YH; Kim SM; Shin HY J Clin Neurol; 2016 Oct; 12(4):482-488. PubMed ID: 27819419 [TBL] [Abstract][Full Text] [Related]
3. Cholinergic hyperactivity in patients with myasthenia gravis with MuSK antibodies: A neurophysiological study. Modoni A; Mastrorosa A; Spagni G; Evoli A Clin Neurophysiol; 2021 Aug; 132(8):1845-1849. PubMed ID: 34147009 [TBL] [Abstract][Full Text] [Related]
4. Neurophysiological characteristics of MuSK antibody positive myasthenia gravis mice: focal denervation and hypersensitivity to acetylcholinesterase inhibitors. Chroni E; Punga AR J Neurol Sci; 2012 May; 316(1-2):150-7. PubMed ID: 22251934 [TBL] [Abstract][Full Text] [Related]
5. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody. Punga AR; Flink R; Askmark H; Stålberg EV Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324 [TBL] [Abstract][Full Text] [Related]
6. Repetitive Nerve Stimulation in MuSK-Antibody-Positive Myasthenia Gravis. Kim SW; Sunwoo MK; Kim SM; Shin HY; Sunwoo IN J Clin Neurol; 2017 Jul; 13(3):287-292. PubMed ID: 28516744 [TBL] [Abstract][Full Text] [Related]
7. Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis. Oh SJ; Hatanaka Y; Hemmi S; Young AM; Scheufele ML; Nations SP; Lu L; Claussen GC; Wolfe GI Muscle Nerve; 2006 Apr; 33(4):500-4. PubMed ID: 16392120 [TBL] [Abstract][Full Text] [Related]
8. Clinical Features and Prognostic Analysis of MuSK-Antibody-Positive Myasthenia Gravis versus Double-Seropositive Myasthenia Gravis: A Single-Center Study from Central South China. He T; Chen K; Li Y; Luo Z; Luo M; Yang H Neuropsychiatr Dis Treat; 2024; 20():725-735. PubMed ID: 38566882 [TBL] [Abstract][Full Text] [Related]
9. [Seronegative myasthenia and myasthenia gravis with anti-MuSK antibody: a retrospective study of 20 cases]. Aubert S; Salort-Campana E; Franques J; Uzenot D; Pouget J Rev Neurol (Paris); 2009 Nov; 165(11):901-10. PubMed ID: 19327804 [TBL] [Abstract][Full Text] [Related]
10. Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis. Wolfe GI; Oh SJ Ann N Y Acad Sci; 2008; 1132():71-5. PubMed ID: 18567855 [TBL] [Abstract][Full Text] [Related]
11. AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review. Lu Y; Ran H; Yang W; Ma Q; Qiu L; Ou C; Chen P; Lin Z; Liu W Neuromuscul Disord; 2020 Jul; 30(7):534-538. PubMed ID: 32387283 [TBL] [Abstract][Full Text] [Related]
12. Association between musk antibody concentrations and the myasthenia gravis composite score in 3 patients: A marker of relapse? Triplett JD; Hardy TA; Riminton DS; Chu SYK; Reddel SW Muscle Nerve; 2019 Sep; 60(3):307-311. PubMed ID: 31177576 [TBL] [Abstract][Full Text] [Related]
13. Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes. Rostedt Punga A; Ahlqvist K; Bartoccioni E; Scuderi F; Marino M; Suomalainen A; Kalimo H; Stålberg EV Clin Neurophysiol; 2006 Jul; 117(7):1434-43. PubMed ID: 16737845 [TBL] [Abstract][Full Text] [Related]
14. [Effects of acetylcholinesterase inhibitors on patients with MuSK antibody positive myasthenia gravis]. Konishi T; Kousaka M; Yamakawa K; Matsui M; Ohta K Rinsho Shinkeigaku; 2009 Oct; 49(10):660-3. PubMed ID: 19999149 [TBL] [Abstract][Full Text] [Related]